Plantar wart cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 21: | Line 21: | ||
[[Category:Foot diseases]] | [[Category:Foot diseases]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Infectious disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 16:40, 19 December 2012
|
Plantar wart Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Plantar wart cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Plantar wart cost-effectiveness of therapy |
|
Risk calculators and risk factors for Plantar wart cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cost-effectiveness of Therapy
A 2006 study assessed the effects of different local treatments for cutaneous, non-genital warts in healthy people. The study reviewed 60 randomized clinical trials dating up to March 2005. The main findings were:
- overall there is a lack of evidence (many trials were excluded because of poor methodology and reporting).
- the average cure rate using a placebo was 27% after an average period of 15 weeks.
- the best treatments are those containing salicylic acid. They are clearly better than placebo.
- there is surprisingly little evidence for the absolute efficacy of cryotherapy.
- two trials comparing salicylic acid and cryotherapy showed no significant difference in efficacy.
- one trial comparing salicylic acid and duct tape occlusion therapy showed no significant difference in efficacy.
- evidence for the efficacy of the remaining treatments was limited.